While hyperkalaemia occurred more frequently with finerenone than with placebo, this was often mild or moderate and resulted in few drug discontinuations (2.3% vs 0.9%, respectively), despite study participants also being on maximum-tolerated RAS inhibitor therapy
The office is extremely clean, welcoming, and organized
Yes, pharmaceutical companies are developing additional dual and triple agonist medications
Your Personalized Path: Our commitment to your success begins with a personalized approach
Common Side Effects That May Impact Weight Loss GLP-1 medications can cause side effects, particularly during the adjustment phase
Check out the infographic below to know what these magical ingredients are and why they can do what they can do